BBK Capital Partners »

Regeneron Pharmaceuticals shares owned by BBK Capital Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by BBK Capital Partners from 13F filings

Historical chart of BBK Capital Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by BBK Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by BBK Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $689k 784 878.29
2023-09-30 $661k 803 822.96
2023-06-30 $793k 1.1k 718.95
2023-03-31 $755k 919 821.55
2022-12-31 $1.3M 1.8k 721.34
2022-09-30 $1.3M 1.8k 688.43
2022-06-30 $1.1M 1.8k 591.57
2022-03-31 $1.1M 1.6k 698.34
2021-12-31 $928k 1.5k 631.29
2021-09-30 $801k 1.3k 605.44